welcome
CNBC

CNBC

Health

Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

CNBC
Summary
Nutrition label

83% Informative

Hims & Hers Health announced plans to expand to Canada in 2026 .

Hims will offer generic copies of semaglutide drugs Ozempic and Wegovy in Canada .

Novo Nordisk will lose its patent protection on its GLP-1s in Canada after not paying a maintenance fee in 2019 .

VR Score

82

Informative language

83

Neutral language

29

Article tone

semi-formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links